Remdesivir Use in Pediatric Patients for SARS-CoV-2 Treatment: Single Academic Center Study.

Allison M SamuelLarissa L HackerJessica ZebrackiMonica C BogenschutzLucas SchulzJill StrayerJoshua P VanderlooPelin CengizSheryl Henderson

Published in: The Pediatric infectious disease journal (2022)

Remdesivir may correlate with clinical stability or improvement and demonstrates safety when used in pediatric patients. A randomized controlled trial is needed to confirm these findings.

Keyphrases

sars cov

respiratory syndrome coronavirus

smoking cessation